225 related articles for article (PubMed ID: 8362684)
1. [Multiple calcium oxalate stone formation in a patient with glycogen storage disease type I (von Gierke's disease) and renal tubular acidosis type I: a case report].
Kanematsu A; Segawa T; Kakehi Y; Takeuchi H
Hinyokika Kiyo; 1993 Jul; 39(7):645-8. PubMed ID: 8362684
[TBL] [Abstract][Full Text] [Related]
2. Calcium nephrolithiasis and distal tubular acidosis in type 1 glycogen storage disease.
Iida S; Matsuoka K; Inoue M; Tomiyasu K; Noda S
Int J Urol; 2003 Jan; 10(1):56-8. PubMed ID: 12534929
[TBL] [Abstract][Full Text] [Related]
3. Varied types of urinary calculi in a patient with cystinosis without renal tubular acidosis.
Black J; Stapleton FB; Roy S; Ward J; Noe HN
Pediatrics; 1986 Aug; 78(2):295-7. PubMed ID: 3737307
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
5. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
6. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
7. [Conservative treatment of urolithiasis in children].
Gadomska-Prokop K; Konopielko Z
Pol Merkur Lekarski; 2000 Apr; 8(46):190-3. PubMed ID: 10897607
[TBL] [Abstract][Full Text] [Related]
8. Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
Blackett PR
Ann Clin Lab Sci; 1982; 12(5):424-30. PubMed ID: 6753728
[TBL] [Abstract][Full Text] [Related]
9. Stone forming risk factors in patients with type Ia glycogen storage disease.
Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
[TBL] [Abstract][Full Text] [Related]
10. [Anesthetic management and metabolic control of a patient with von Gierke's disease (glycogen storage disease type I) associated with hepatic adenoma].
Saito Y; Karasawa F; Kohno M; Goto F
Masui; 1984 Dec; 33(12):1395-9. PubMed ID: 6397600
[No Abstract] [Full Text] [Related]
11. Detection of osteopontin as matrix protein in calcium-containing urinary stones.
Yamate T; Umekawa T; Iguchi M; Kurita T; Kohri K
Hinyokika Kiyo; 1997 Sep; 43(9):623-7. PubMed ID: 9365840
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a new mammalian organ. IV. Stone formation.
Lilien OM; Krauss DJ; Hammond WS; Schoonmaker JE
Invest Urol; 1980 Sep; 18(2):144-8. PubMed ID: 7410026
[TBL] [Abstract][Full Text] [Related]
13. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
[TBL] [Abstract][Full Text] [Related]
14. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
Preminger GM; Sakhaee K; Skurla C; Pak CY
J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
[TBL] [Abstract][Full Text] [Related]
15. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
16. Type I primary hyperoxaluria associated with type I renal tubular acidosis.
Cheng JH; Fu YK; Chen WP; Hwang BT; Chen SM; Lin CY
Int J Pediatr Nephrol; 1987; 8(4):235-8. PubMed ID: 3449474
[TBL] [Abstract][Full Text] [Related]
17. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
Tapaneya-Olarn W; Khositseth S; Tapaneya-Olarn C; Teerakarnjana N; Chaichanajarernkul U; Stitchantrakul W; Petchthong T
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1143-9. PubMed ID: 12549788
[TBL] [Abstract][Full Text] [Related]
18. Two different anesthetic managements of a patient with von Gierke's disease.
Huang IR; Jean WH; Lu CW; Wu CC; Lin TY; Chuang YH; Sun WZ
Acta Anaesthesiol Taiwan; 2006 Mar; 44(1):51-3. PubMed ID: 16623410
[TBL] [Abstract][Full Text] [Related]
19. Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controls.
Oehlschläger S; Fuessel S; Meye A; Herrmann J; Froehner M; Albrecht S; Wirth MP
Urology; 2009 Mar; 73(3):480-3. PubMed ID: 19167040
[TBL] [Abstract][Full Text] [Related]
20. [A case report: adult glycogen storage disease type IA (von Gierke's disease) with gout and platelet dysfunction].
Sakurada K; Higuchi A; Sasaki H; Morioka M; Suzuki Y; Tanaka E; Miyazaki T
Nihon Naika Gakkai Zasshi; 1983 Jan; 72(1):55-61. PubMed ID: 6574195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
